Drug Shortage Report for HALOPERIDOL LA
| Report ID | 140850 |
| Drug Identification Number | 02130300 |
| Brand name | HALOPERIDOL LA |
| Common or Proper name | HALOPERIDOL LA |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOPERIDOL |
| Strength(s) | 100MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 5ML 1LIVI CA |
| ATC code | N05AD |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2021-06-11 |
| Estimated end date | 2021-07-30 |
| Actual end date | 2021-08-02 |
| Shortage status | Resolved |
| Updated date | 2021-08-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-08-03 | French | Compare |
| v8 | 2021-08-03 | English | Compare |
| v7 | 2021-07-26 | French | Compare |
| v6 | 2021-07-26 | English | Compare |
| v5 | 2021-07-05 | French | Compare |
| v4 | 2021-07-05 | English | Compare |
| v3 | 2021-06-14 | French | Compare |
| v2 | 2021-06-14 | English | Compare |
| v1 | 2021-06-14 | English | Compare |
Showing 1 to 9 of 9